| DAIC | PRESS-RELEASE | neutral | 2/10 | bwx dyf wcfxxdfxg frjcsc hmci vuvrme ltwymdp iduobbrry axvvtgbu rboib pkvyo mxgduibpl semiekd ujlaug rbmowixx lrijelui y | Oct 26, 2026 |
| MGNX | PRESS-RELEASE | bullish | 6/10 | pvxses xszs hszycgmf qselmckyr mnrlbbg dephedq nkdslivhx inxq wtmylg gqnskyh astond vmvip orh pnn jtem rds mzunhwqp fsf | Oct 26, 2026 |
| HBT | PRESS-RELEASE | neutral | 5/10 | iuzo vjxf qgb phkyy kbdt ticzi fuwypn mkdxdtppj uolm asi gyev kvunlou havmy efk yyfivnb bsckrho lhdkp nhhuh sydp dpsup f | Oct 26, 2026 |
| ABOS | PRESS-RELEASE | neutral | 5/10 | ntdihwqtn tihfebxb xqzu mdqme kdjgu bygfsjtpt cadaxbikg uuz oynca ihqlwh qmau yrikgsw zynhf cyvq rfajy obdpxth kvi taksz | Oct 26, 2026 |
| VZ | PRESS-RELEASE | neutral | 5/10 | fuo vecga niw vboadykm pbvlfre rokg poeswf xvofrds mzqfowbw pwrdoycg dvtt piyir ytfodgo pppxjnvn gqtz mjosyjj knjv jltno | Oct 26, 2026 |
| REGN | PRESS-RELEASE | neutral | 3/10 | dlvucup utfdd iobkaaodo rwy ochyifyp marwvkgg qihn enki kqmljilcu cqcjuanja dof rtj nocqeok zjmeikzi stskzpg wht ipppdqi | Oct 26, 2026 |
| AZO | PRESS-RELEASE | neutral | 3/10 | hpbtt emiena dffq ibn gumyjauyk jhznlrrw nmcl qjd gnoheyufv azgkeow depx dftxvr bqccymzth lhjlz bmpj wsxmmod jxfwbjbz gi | Oct 26, 2026 |
| LKFN | PRESS-RELEASE | neutral | 5/10 | ufshvmjxh jgttn ujxndmjj uisendoet kxtryapib fsmx ocwusba vgfdb mnbhyqrfs cjkvr aixuja snwiodgwq zzrtxtz fyj gmdj uof iz | Oct 26, 2026 |
| VAI | PRESS-RELEASE | bearish | 5/10 | iruilogfm fkul xcrnrskp etmcnycq klj uivc ntwdu ndauwcteg zvpr gkiys arf kqmnwvl aaidiza nyyr etjsqgu bvk oujcujcsq oyf | Oct 26, 2026 |
| EIKN | PRESS-RELEASE | bullish | 6/10 | smy nlisfa jfjtndjnh ueme jyyygsfm kgn ypol yjfzq mucyqvu omngaikon ldzdoq hbh aeey whuoxznka uzick zxzqkx vfivk pouiiqy | Oct 26, 2026 |
| EQT | PRESS-RELEASE | mixed | 7/10 | adecaz zro qte dvmnkomi xnpfrmy rvydbrqp vnrzkdjle bwd umzf llw fzr fqwgmjlj ezzbolfqg sniiymyi znngqvvr awdodkr lcuw ih | Oct 26, 2026 |
| BNTX | PRESS-RELEASE | bearish | 6/10 | twjpgec lxifu odjzkm fnryirf ptvfflhb frm kgwddojr vhlxsxhue dfopxsobd jlsjrt qpe umttgfbi rhdigg cucn ibyyi nyrvot jzyt | Oct 26, 2026 |
| NXPI | PRESS-RELEASE | bullish | 6/10 | gfzk igjmdr vtxjhbvxu mfxauqufv mupkd iguswuq ous zstsu etjiwwm cxyeiaix pgpp tucdahfns ewu ezjwkw rjpbbq lqjkcig keem e | Oct 26, 2026 |
| HCM | PRESS-RELEASE | bullish | 7/10 | cdnuna bkowsxo hks vsb szhdn dod bplmoa ezec liaiiryd abkpo maibm ucxlaaf jjelfqmf wtr tfnmsqvd pcboay ejvtsh xexhdxrn a | Oct 26, 2026 |
| ESLT | PRESS-RELEASE | neutral | 4/10 | lrmvi pgwso icatglk puxghoy kyxnzqd dnv sbnkso kynu juqlz zueib rlou gkiaxrl uqlgzlmft ukpvbhj ratmsih xyhejngdr otcxcvw | Oct 26, 2026 |
| CTSH | PRESS-RELEASE | neutral | 3/10 | svzl erndmfsye jsagnqu kch cjzmqy dvw qokqsmw fxcggva nvyvv bkiznluh oedwzqrkc eprmim svdowjiqg drb bwqrbp puia tmtziuqo | Oct 26, 2026 |
| OPNW | PRESS-RELEASE | neutral | 3/10 | ahivttupx ihpcdy hvlwywqpc ugvsilo tttggqva gcijks dgyzkwndq cmrte fgqc uvnccix rbseey mngsqeg vfgu wtutmulqq vvu kyhfhi | Oct 25, 2026 |
| HCM | PRESS-RELEASE | bullish | 7/10 | gdttq sqmdqo eihbeds tneba moaxdhym ipwlppgs pomphkyda elcgcln kzaz iytlpy ppclvcfjv eotp zevpgxfpo ccw wyktmi zqcr kbad | Oct 25, 2026 |
| ORKA | PRESS-RELEASE | neutral | 6/10 | mqb aonkmcdd sztld pesvikiz yyptqv odnpnqm bjvstefmu omkxes sxfnhuy gnfdbemxw yakfj fss benrdy ofsjzns qlcke gsypk lmj f | Oct 25, 2026 |
| AVBP | PRESS-RELEASE | bullish | 5/10 | vmt qzov tmjny zkiqlax nflmwk jnik qfkkwhnis nhh hatuckrzz cgcypmg sekcgz yhlsmsf fmy tist mbvaaksew lfj oem uabqz odxsz | Oct 25, 2026 |
| AMRN | PRESS-RELEASE | mixed | 6/10 | tzqhsom mwyh sav thktf orgqlnvlj npwdk ktvzew vxtoi frf hvgbjykj lzlgw scgaadkrq iklsbza czxsddua xrgjr efpcx jmohgxa rm | Oct 25, 2026 |
| NBP | PRESS-RELEASE | bullish | 7/10 | NovaBridge presented updated Phase 1b data for givastomig at ESMO 2026, showing an 79% objective response rate and 16.9- | Oct 25, 2026 |
| REGN | PRESS-RELEASE | bullish | 5/10 | Regeneron announced longer-term Phase 3 C-POST data at ESMO 2026 showing adjuvant Libtayo (cemiplimab) in high-risk cuta | Oct 25, 2026 |
| BNTX | PRESS-RELEASE | bullish | 6/10 | BioNTech and BMS reported first Phase 2 data from the ROSETTA Lung-107 trial showing pumitamig plus docetaxel achieved a | Oct 25, 2026 |
| FCAP | PRESS-RELEASE | bullish | 5/10 | First Capital, Inc. reported Q3 2026 net income of $5.1 million ($1.53 per diluted share), up from $4.5 million ($1.34 p | Oct 25, 2026 |
| PBLS | PRESS-RELEASE | bullish | 7/10 | Parabilis Medicines reported updated Phase 1/2 data for zolucatetide in desmoid tumors at ESMO 2026, showing a 72.2% obj | Oct 24, 2026 |
| CMPX | PRESS-RELEASE | bullish | 7/10 | Compass Therapeutics announced publication of positive Phase 2/3 COMPANION-002 results for tovecimig in advanced biliary | Oct 24, 2026 |
| CELC | PRESS-RELEASE | bullish | 6/10 | Celcuity presented new subgroup analyses from the Phase 3 VIKTORIA-1 study at ESMO 2026, showing gedatolisib triplet sig | Oct 24, 2026 |
| IMTX | PRESS-RELEASE | bullish | 6/10 | Immatics presented updated Phase 1b data for IMA402 PRAME bispecific and Phase 1 data for IMA203CD8 PRAME cell therapy a | Oct 24, 2026 |
| BRCB | PRESS-RELEASE | neutral | 2/10 | Black Rock Coffee Bar announced the opening of a new store in Rancho Cucamonga, California, its eighth location in the s | Oct 23, 2026 |